---
layout: page-fullwidth
title: "Publications"
subheadline: ""
teaser: "(Peer-reviewed journal articles)"
permalink: "/publications/"
---
`Asterisks * indicate joint first authors`

34: Performance evaluation of automated white matter hyperintensity segmentation algorithms in a multicenter cohort on cognitive impairment and dementia.
:   Gaubert, M., Dell’Orco, … & DELCODE Study Group (<b>Kobeleva, X.</b> part of DECLODE Study Group) (2023).<br><b><u>Frontiers in Psychiatry</u></b>, 13, 1010273.  [→ DOI](https://doi.org/10.3389/fpsyt.2022.1010273)

33: Linking early-life bilingualism and cognitive advantage in older adulthood.
:   Ballarini, T., Kuhn, E., Röske, S., … <b>Kobeleva, X.</b>, … & DELCODE Study Group (2023).<br><b><u>Neurobiology of Aging</u></b>, 124, 18-28.  [→ DOI](https://doi.org/10.1016/j.neurobiolaging.2022.12.005)

32: Subjective cognitive decline and stage 2 of Alzheimer disease in patients from memory centers.
:   Jessen, F., Wolfsgruber, S., Kleineindam, L., … <b>Kobeleva, X.</b>, … & Düzel, E. (2023).<br><b><u>Alzheimer's & Dementia</u></b>, 19(2), 487-497.  [→ DOI](https://doi.org/10.1002/alz.12674)

31: Midlife occupational cognitive requirements protect cognitive function in old age by increasing cognitive reserve.
:   Kleineidam, L., Wolfsgruber, S., Weyrauch, A.-S., … <b>Kobeleva, X.</b>, … & Wagner, M. (2022).<br><b><u>Frontiers in Psychology</u></b>, 13, 957308.  [→ DOI](https://doi.org/10.3389/fpsyg.2022.957308)

30: Coherent structural and functional network changes after Nucleus Ventralis Intermedius lesion in Essential Tremor.
:   Pohl, E.`*`, Upadhuay, N.`*`, <b>Kobeleva, X.</b>`*`, … & Boecker, H. (2022).<br><b><u>Movement Disorders</u></b>, 37(9), 1924-1929.  [→ DOI](https://doi.org/10.1002/mds.29130)

29: Advancing brain network models to reconcile functional neuroimaging and clinical research.
:   <b>Kobeleva, X.</b>, Varoquaux, G., Dagher A., Adhikari, M., Grefkes, C., Gilson, M. (2022).<br><b><u>NeuroImage Clinical</u></b>, 36, 103262.  [→ DOI](https://doi.org/10.1016/j.nicl.2022.103262)

28: Adult-Onset Neurodegeneration in Nucleotide Excision Repair Disorders (NERD<sub>ND</sub>): Time to Move Beyond the Skin.
:   Cordts, E., Oender, D., Traschütz, A., <b>Kobeleva, X.</b>, … & Deschauer, M. (2022).<br><b><u>Movement Disorders</u></b>, 37(8), 1707-1718.  [→ DOI](https://doi.org/10.1002/mds.29071)

27: Revealing the relevant spatiotemporal scale underlying whole-brain dynamics.
:   <b>Kobeleva, X.</b>, López-González, A., Kringelbach, M., & Deco, G. (2021).<br><b><u>Frontiers in Neuroscience</u></b>, 15, 715861.  [→ DOI](https://doi.org/10.3389/fnins.2021.715861)

26: Brain activity is contingent on neuropsychological function in an fMRI study of Verbal Working Memory in Amyotrophic Lateral Sclerosis.
:   <b>Kobeleva, X.</b>, Machts, J., Veit, M., Vielhaber, S., Petri, S., & Schoenfeld, M.A. (2021).<br><b><u>European Journal of Neurology</u></b>, 28(89), 3051-3060.  [→ DOI](https://doi.org/10.1111/ene.14957)

25: Clinically applicable quantitative magnetic resonance morphologic measurements of grey matter changes in the human brain.
:   Fu, T., <b>Kobeleva, X.</b>, Bronzlik, P., Nösel, P., Dadak, M., Lanfermann, H., Petri, S., Ding X. (2021).<br><b><u>Brain Sciences</u></b>, 11(1), 55.  [→ DOI](https://doi.org/10.3390/brainsci11010055)

24: Brainhack: Developing a culture of open, inclusive, community-driven neuroscience.
:   Gau, R., Noble, S., …, <b>Kobeleva, X.</b>, … & The Brainhack Community (2021).<br><b><u>Neuron</u></b>, 109(11), 1769-1775.  [→ DOI](https://doi.org/10.1016/j.neuron.2021.04.001)

23: Centering inclusivity in the design of online conferences—An OHBM–Open Science perspective.
:   Levitis, E., van Praag, CDG, …, <b>Kobeleva, X.</b>, … & Maumet, C. (2021).<br><b><u>GigaScience</u></b>, 10(8), giab051.  [→ DOI](https://doi.org/10.1093/gigascience/giab051)

22: Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers—results from the DELCODE study.
:   Sannemann, L., Schild, A.-K., … <b>Kobeleva, X.</b>, … & Jessen, F. (2020).<br><b><u>Alzheimer's Research & Therapy</u></b>, 12(1), 1-11.  [→ DOI](https://doi.org/10.1186/s13195-020-00701-7)

21: Minor neuropsychological deficits in patients with subjective cognitive decline.
:   Wolfsgruber, S., Kleineidam L., … & DELCODE Study Group (<b>Kobeleva, X.</b> part of DECLODE Study Group) (2020).<br><b><u>Neurology</u></b>, 95(9), e1134-e1143.  [→ DOI](https://doi.org/10.1212/WNL.0000000000010142)

20: Bi-allelic HPDL variants cause a neurodegenerative disease ranging from Neonatal Encephalopathy to Adolescent-Onset Spastic Paraplegia.
:   Husain, R.A., Grimmel, A., … <b>Kobeleva, X.</b>, … Haack, T.B. (2020).<br><b><u>American Journal of Human Genetics</u></b>, 107(2), 364-373.  [→ DOI](https://doi.org/10.1016/j.ajhg.2020.06.015)

19: Truncating Mutations in UBAP1 Cause Hereditary Spastic Paraplegia.
:   Fard, M. A. F., Rebelo, A. P., Buglo, E., Nemati, H., Dastsooz, H., Gehweiler, I., … <b>Kobeleva, X.</b>, … & Cortese, A. (2019).<br><b><u>The American Journal of Human Genetics</u></b>, 104(4), 767-773.  [→ DOI](https://doi.org/10.1016/j.ajhg.2019.03.001)

18: Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.
:   Ludolph, A. C., Schuster, … & RAS-ALS Study Group (<b>Kobeleva, X.</b> part of RAS-ALS Study Group) (2018).<br><b><u>The Lancet Neurology</u></b>, 17(8), 681-688.  [→ DOI](https://doi.org/10.1016/S1474-4422(18)30176-5)

17: Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model.
:   Westeneng, H. J., Debray, T. P., Visser, A. E., van Eijk, R. P., Rooney, J. P., Calvo, A., … <b>Kobeleva, X.</b>, … & van den Berg, L. H. (2018).<br><b><u>The Lancet Neurology</u></b>, 17(5), 423-433.  [→ DOI](https://doi.org/10.1016/S1474-4422(18)30089-9)

16: Electroencephalographic derived network differences in Lewy body dementia compared to Alzheimer’s disease patients.
:   Peraza, L. R., Cromarty, R., <b>Kobeleva, X.</b>, Firbank, M. J., Killen, A., Graziadio, S., … & Taylor, J.-P. (2018).<br><b><u>Scientific Reports</u></b>, 8(1), 4637.  [→ DOI](https://doi.org/10.1038/s41598-018-22984-5)

15: Divergent functional connectivity during attentional processing in Lewy body dementia and Alzheimer's disease.
:   <b>Kobeleva, X.</b>`*`, Firbank, M.`*`, Peraza, L., Gallagher, P., Thomas, A., Burn, D. J., … & Taylor, J. P. (2017).<br><b><u>Cortex</u></b>, 92, 8-18.  [→ DOI](https://doi.org/10.1016/j.cortex.2017.02.016)

14: Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial.
:   Meininger, V., Genge, A., … & NOG112264 Study Group (<b>Kobeleva, X.</b> part of NOG112264 Study Group) (2017).<br><b><u>The Lancet Neurology</u></b>, 16(3), 208-216.  [→ DOI](https://doi.org/10.1016/S1474-4422(16)30399-4)

13: Forschung für Alle in der Junge-Neurologen-Postersession *(in German language)*.
:   <b>Kobeleva, X.</b> (2017).<br><b><u>NeuroTransmitter</u></b>, S1/2017, 54.  [→ DOI](https://www.springermedizin.de/forschung-fuer-alle-in-der-junge-neurologen-postersession/14993934)

12: Working memory network changes in ALS: an fMRI Study.
:   Vellage, A. K., Veit, M., <b>Kobeleva, X.</b>, Petri, S., Vielhaber, S., & Müller, N. G. (2016).<br><b><u>Frontiers in Neuroscience</u></b>, 10, 158.  [→ DOI](https://doi.org/10.3389/fnins.2016.00158)

11: Neural correlates of attention‐executive dysfunction in lewy body dementia and Alzheimer's disease.
:   Firbank, M.`*`, <b>Kobeleva, X.</b>`*`, Cherry, G., Killen, A., Gallagher, P., Burn, D. J., … & Taylor, J. P. (2016).<br><b><u>Human Brain Mapping</u></b>, 37(3), 1254-1270.  [→ DOI](https://doi.org/10.1002/hbm.23100)

10: Hilfsmittelversorgung bei der amyotrophen Lateralsklerose *(in German language)*.
:   Funke, A., Grehl, T., Großkreutz, J., Münch, C., Walter, B., Kettemann, D., … <b>Kobeleva, X.</b>, … & Meyer, T. (2015).<br><b><u>Der Nervenarzt</u></b>, 86(8), 1007-1017.  [→ DOI](https://doi.org/10.1007/s00115-015-4398-2)

9: International Issues: An international survey of young neurologists’ perceptions of future health care and neurology.
:   Macerollo, A., Róna-Vörös, K., Struhal, W., <b>Kobeleva, X.</b>, & Sellner, J. (2015).<br><b><u>Neurology</u></b>, 84(4), e20-e23.  [→ DOI](https://doi.org/10.1212/WNL.0000000000001180)

8: Dissociation of explicit and implicit measures of the behavioral inhibition and activation system in borderline personality disorder.
:   <b>Kobeleva, X.</b>, Seidel, E. M., Kohler, C., Schneider, F., Habel, U., & Derntl, B. (2014).<br><b><u>Psychiatry Research</u></b>, 218(1-2), 134-142.  [→ DOI](https://doi.org/10.1016/j.psychres.2014.04.027)

7: International Issues: Cross-border mobility of junior neurologists within and to the European Union.
:   Macerollo, A., Varga, E. T., Struhal, W., Györfi, O., <b>Kobeleva, X.</b>, & Sellner, J. (2014).<br><b><u>Neurology</u></b>, 83(13), e128-e131.  [→ DOI](https://doi.org/10.1212/WNL.0000000000000813)

6: Varicella zoster-associated retinal and central nervous system vasculitis in a patient with multiple sclerosis treated with natalizumab.
:   <b>Kobeleva, X.</b>, Wegner, F., Brunotte, I., Dadak, M., Dengler, R., & Stangel, M. (2014).<br><b><u>Journal of Neuroinflammation</u></b>, 11(1), 19.  [→ DOI](https://doi.org/10.1186/1742-2094-11-19)

5: DGN-Kongress 2013. Wo muss ich hin? – Medizin für kluge Köpfe *(in German language)*.
:   Ossig, C., <b>Kobeleva, X.</b>, Wilcken, S., Müller, L., Bernhard, F., & Angermaier, A. (2013).<br><b><u>NeuroTransmitter</u></b>, S1/2013, 50-52.  [→ DOI](https://www.springermedizin.de/wo-muss-ich-hin-medizin-und-mehr-fuer-kluge-koepfe/9317426)

4: The European Association of Young Neurologists and Trainees in 2013: striking a blow for European junior neurologists.
:   Macerollo, A., Varga, E. T., Györfi, O., <b>Kobeleva, X.</b>, Paterson, R. W., & Sellner, J. (2013).<br><b><u>European Journal of Neurology</u></b>, 20(4), e54-e58.  [→ DOI](https://doi.org/10.1111/ene.12114)

3: Barriers to novel therapeutics in amyotrophic lateral sclerosis.
:   <b>Kobeleva, X.</b>, & Petri, S. (2013).<br><b><u>Neurodegenerative Disease Management</u><b/>, 3(6), 525-537.  [→ DOI](https://doi.org/10.2217/nmt.13.66)

2: E-learning preferences of European junior neurologists—an EAYNT survey.
:   Sztriha, L. K., Varga, E. T., Róna-Vörös, K., Holler, N., Ilea, R., <b>Kobeleva, X.</b>, ... & Sellner, J. (2012).<br><b><u>Frontiers in Neurology</u><b/>, 3, 167. [→ DOI](https://doi.org/10.3389/fneur.2012.00167)

1: Nachwuchsarbeit 2011 auf nationaler und europäischer Ebene: Die Aktivitäten der Jungen Neurologen und der EAYNT *(in German language)*.
:   Holler, N., <b>Kobeleva, X.</b>, Hilienhof, A., Wolz, M., & Sellner, J. (2011).<br><b><u>Aktuelle Neurologie</u><b/>, 38(01), 45-47.  [→ DOI](https://doi.org/10.1055/s-0030-1266062)

<br>

<div style="text-align: center;">
<a class="radius button small" href="{{ site.url }}{{ site.baseurl }}/team/">‹ Go back to the team page</a>
<a class="radius button small" href="{{ site.url }}{{ site.baseurl }}/non-expert-info/">Go to our secion with non-technical information ›</a>
</div>

<br><br>
